Retracted Alzheimer Study Flagged for Image Manipulation and Data Duplication
A 2018 paper on antileukotriene therapy and tau phosphorylation in Alzheimer's mice has been retracted due to image fraud.
Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
301 articles
A 2018 paper on antileukotriene therapy and tau phosphorylation in Alzheimer's mice has been retracted due to image fraud.
MethylCog, a 29-CpG blood test, indexes general cognitive ability and improves mild cognitive impairment detection beyond age and sex alone.
A 9-day intranasal insulin regimen restored working memory, recognition memory, and reduced neuroinflammation in mice engineered to mimic hippocampal aging.
Leading neurologists argue that amyloid aggregation dynamics may be distorting how we read clinical trial results for Alzheimer's immunotherapies.
A multi-omics subspace-merging algorithm identifies biologically distinct AD subtypes, pointing toward personalized treatment strategies.
A newly identified GABAergic pathway in mice lets the brain toggle between updated and previous memories — a key insight for memory disorders.
MIT's self-organizing laser creates ultra-sharp brain images 25x faster, enabling real-time tracking of drugs crossing the blood-brain barrier.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits — reshaping diagnosis and treatment.
A new review reveals that disrupted mito-nuclear signaling may precede amyloid and tau pathology, opening fresh therapeutic targets for Alzheimer's.
A Framingham study of 2,844 adults links impaired endothelial function to higher Alzheimer's risk, brain shrinkage, and white matter damage.
A new AI classifier using just 15 proteins achieves 95.5% AUC accuracy across Alzheimer's, Parkinson's, FTD, and Lewy body dementia.